Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol.

Holyoake DL, Ward E, Grose D, McIntosh D, Sebag-Montefiore D, Radhakrishna G, Patel N, Silva M, Mukherjee S, Strauss VY, Odondi L, Fokas E, Melcher A, Hawkins MA.

BMC Cancer. 2016 Sep 13;16(1):728. doi: 10.1186/s12885-016-2765-4.

2.

Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancreatic stump and other stump.

Zeng XL, Wang HH, Meng MB, Wu ZQ, Song YC, Zhuang HQ, Qian D, Li FT, Zhao LJ, Yuan ZY, Wang P.

Onco Targets Ther. 2016 Jun 30;9:3985-92. doi: 10.2147/OTT.S102784. eCollection 2016.

3.

Therapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study.

Marsico M, Gabbani T, Livi L, Biagini MR, Galli A.

World J Hepatol. 2016 Jun 18;8(17):731-8. doi: 10.4254/wjh.v8.i17.731.

4.

Stereotactic body radiotherapy for the pancreas: a critical review for the medical oncologist.

Kim SK, Wu CC, Horowitz DP.

J Gastrointest Oncol. 2016 Jun;7(3):479-86. doi: 10.21037/jgo.2015.10.01. Review.

5.

What are the current and potential future roles for endoscopic ultrasound in the treatment of pancreatic cancer?

Oh SY, Irani S, Kozarek RA.

World J Gastrointest Endosc. 2016 Apr 10;8(7):319-29. doi: 10.4253/wjge.v8.i7.319. Review.

6.

Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer.

Chuong MD, Frakes JM, Figura N, Hoffe SE, Shridhar R, Mellon EA, Hodul PJ, Malafa MP, Springett GM, Centeno BA.

J Gastrointest Oncol. 2016 Apr;7(2):221-7. doi: 10.3978/j.issn.2078-6891.2015.075.

7.

Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer.

Dagoglu N, Callery M, Moser J, Tseng J, Kent T, Bullock A, Miksad R, Mancias JD, Mahadevan A.

J Cancer. 2016 Jan 10;7(3):283-8. doi: 10.7150/jca.13295. eCollection 2016.

8.

Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.

Shaib WL, Ip A, Cardona K, Alese OB, Maithel SK, Kooby D, Landry J, El-Rayes BF.

Oncologist. 2016 Feb;21(2):178-87. doi: 10.1634/theoncologist.2015-0316. Epub 2016 Feb 1. Review.

PMID:
26834159
9.

Therapeutic role of endoscopic ultrasound in pancreaticobiliary disease: A comprehensive review.

Meng FS, Zhang ZH, Ji F.

World J Gastroenterol. 2015 Dec 14;21(46):12996-3003. doi: 10.3748/wjg.v21.i46.12996. Review.

10.

Pancreatic cancer and SBRT: A new potential option?

Hajj C, Goodman KA.

Rep Pract Oncol Radiother. 2015 Sep-Oct;20(5):377-84. doi: 10.1016/j.rpor.2015.05.008. Epub 2015 Jun 28. Erratum in: Rep Pract Oncol Radiother. 2015 Nov-Dec;20(6):491.

11.

Advances of stereotactic body radiotherapy in pancreatic cancer.

Wei Q, Yu W, Rosati LM, Herman JM.

Chin J Cancer Res. 2015 Aug;27(4):349-57. doi: 10.3978/j.issn.1000-9604.2015.04.12. Review.

12.

Robotic radiosurgery in pancreatic cancer: A systematic review.

Buwenge M, Cellini F, Silvestris N, Cilla S, Deodato F, Macchia G, Mattiucci GC, Valentini V, Morganti AG.

World J Gastroenterol. 2015 Aug 21;21(31):9420-9. doi: 10.3748/wjg.v21.i31.9420.

13.

Adaptive motion mapping in pancreatic SBRT patients using Fourier transforms.

Jones BL, Schefter T, Miften M.

Radiother Oncol. 2015 May;115(2):217-22. doi: 10.1016/j.radonc.2015.03.029. Epub 2015 Apr 15.

14.

Prospective therapies for high-grade glial tumours: A literature review.

Talibi SS, Talibi SS, Aweid B, Aweid O.

Ann Med Surg (Lond). 2014 May 21;3(3):55-9. doi: 10.1016/j.amsu.2014.04.003. eCollection 2014 Sep. Review.

15.

The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience.

Moningi S, Dholakia AS, Raman SP, Blackford A, Cameron JL, Le DT, De Jesus-Acosta AM, Hacker-Prietz A, Rosati LM, Assadi RK, Dipasquale S, Pawlik TM, Zheng L, Weiss MJ, Laheru DA, Wolfgang CL, Herman JM.

Ann Surg Oncol. 2015 Jul;22(7):2352-8. doi: 10.1245/s10434-014-4274-5. Epub 2015 Jan 7.

16.

Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.

Herman JM, Chang DT, Goodman KA, Dholakia AS, Raman SP, Hacker-Prietz A, Iacobuzio-Donahue CA, Griffith ME, Pawlik TM, Pai JS, O'Reilly E, Fisher GA, Wild AT, Rosati LM, Zheng L, Wolfgang CL, Laheru DA, Columbo LA, Sugar EA, Koong AC.

Cancer. 2015 Apr 1;121(7):1128-37. doi: 10.1002/cncr.29161. Epub 2014 Dec 23.

17.

Feasibility of automated pancreas segmentation based on dynamic MRI.

Gou S, Wu J, Liu F, Lee P, Rapacchi S, Hu P, Sheng K.

Br J Radiol. 2014 Dec;87(1044):20140248. doi: 10.1259/bjr.20140248. Epub 2014 Oct 1.

18.

Determination of acquisition frequency for intrafractional motion of pancreas in CyberKnife radiotherapy.

Zhang H, Zhao G, Djajaputra D, Xie Y.

ScientificWorldJournal. 2014;2014:408019. doi: 10.1155/2014/408019. Epub 2014 May 13.

19.

Role of endoscopic ultrasound in treatment of pancreatic cancer.

Guo X, Cui Z, Hu Z.

Endosc Ultrasound. 2013 Oct;2(4):181-9. doi: 10.4103/2303-9027.121238. Review.

20.

Bringing the heavy: carbon ion therapy in the radiobiological and clinical context.

Schlaff CD, Krauze A, Belard A, O'Connell JJ, Camphausen KA.

Radiat Oncol. 2014 Mar 28;9(1):88. doi: 10.1186/1748-717X-9-88. Review.

Items per page

Supplemental Content

Write to the Help Desk